tiprankstipranks
Chimeric Therapeutics Ltd. (AU:CHM)
ASX:CHM
Australian Market

Chimeric Therapeutics Ltd. (CHM) Financial Statements

1 Followers

Chimeric Therapeutics Ltd. Financial Overview

Chimeric Therapeutics Ltd.'s market cap is currently ―. The company's EPS TTM is AU$-0.027; its P/E ratio is -0.97; Chimeric Therapeutics Ltd. is scheduled to report earnings on September 27, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22
Income Statement-
Total Revenue-
Gross Profit-
EBIT-
EBITDA-
Net Income Common Stockholders-
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 18.38M
Total AssetsAU$ 34.88M
Total DebtAU$ 0.00
Net DebtAU$ -18.38M
Total LiabilitiesAU$ 9.17M
Stockholders EquityAU$ 25.71M
Cash Flow-
Free Cash Flow-
Operating Cash Flow-
Investing Cash Flow-
Financing Cash Flow-
Currency in AUD

Chimeric Therapeutics Ltd. Earnings and Revenue History

Chimeric Therapeutics Ltd. Debt to Assets

Chimeric Therapeutics Ltd. Cash Flow

Chimeric Therapeutics Ltd. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis